Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL179262 | 0.81 | GOT1 (0.38) | GOT1P2RX7 | |
| SCHEMBL11125404 | 0.79 | GOT1 (0.31) | GOT1 | |
| Hydrochloric Acid SCHEMBL31617638 | 0.79 | GOT1 (0.37) | GOT1P2RX7 | |
| SCHEMBL21169013 | 0.78 | KIF11 (0.34) | GOT1 | |
| SCHEMBL20128939 | 0.77 | GOT1 (0.35) | GOT1P2RX7 | |
| SCHEMBL19872223 | 0.77 | GOT1 (0.35) | GOT1P2RX7 | |
| SCHEMBL29083684 | 0.77 | GOT1 (0.35) | GOT1P2RX7 | |
| SCHEMBL3464064 | 0.75 | — | — | |
| SCHEMBL23196492 | 0.74 | GOT1 (0.33) | GOT1 | |
| SCHEMBL4357788 | 0.74 | GOT1 (0.33) | GOT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0455533-B1 | Process for the production of benzyl methacrylate and its aromatic ring substituted halogenated and alkylated derivatives | ATOCHEM (FR) | 1993-12-15 | — | — | EP | claimed |
| US-5169980-A | Catalytic reaction of benzyl chloride and alkali metal methacrylate | ELF ATOCHEM S.A. (FR) | 1992-12-08 | — | — | US | claimed |
| EP-0455533-A1 | Process for the production of benzyl methacrylate and its aromatic ring substituted halogenated and alkylated derivatives | ELF ATOCHEM S.A. (FR) | 1991-11-06 | — | — | EP | claimed |
| JP-5043513-A | — | — | None | — | — | JP | disclosed |
| CN-116675727-A | Method for synthesizing amide and/or polypeptide by taking unprotected amino acid as ammonia component | 广州医科大学 | 2023-09-01 | — | — | CN | disclosed |
| US-8129389-B2 | Substituted oxindole derivatives, medicaments containing the latter and use thereof | ABBOTT GMBH & CO. KG (DE) | 2012-03-06 | — | — | US | disclosed |
| US-8129389-B2 | Substituted oxindole derivatives, medicaments containing the latter and use thereof | ABBOTT GMBH & CO. KG (DE) | 2012-03-06 | — | — | US | disclosed |
| US-20090186904-A1 | Substituted Oxindole Derivatives, Medicaments Containing the Latter and Use Thereof | ABBOTT GMBH & CO. KG | 2009-07-23 | — | — | US | disclosed |
| US-20090186904-A1 | Substituted Oxindole Derivatives, Medicaments Containing the Latter and Use Thereof | ABBOTT GMBH & CO. KG | 2009-07-23 | — | — | US | disclosed |
| EP-0455533-B1 | Process for the production of benzyl methacrylate and its aromatic ring substituted halogenated and alkylated derivatives | ATOCHEM (FR) | 1993-12-15 | — | — | EP | disclosed |
| JP-H0543513-A | NEW PRODUCTION METHOD OF BENZYL METHACRYLATE AND ITS DERIVATIVE WHICH ARE HALOGENATED OR ALKYLATED ON AROMATIC NUCLEUS | ELF ATOCHEM SA | 1993-02-23 | — | — | JP | disclosed |
| US-5169980-A | Catalytic reaction of benzyl chloride and alkali metal methacrylate | ELF ATOCHEM S.A. (FR) | 1992-12-08 | — | — | US | disclosed |
| EP-0455533-A1 | Process for the production of benzyl methacrylate and its aromatic ring substituted halogenated and alkylated derivatives | ELF ATOCHEM S.A. (FR) | 1991-11-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186904-A1 | Substituted Oxindole Derivatives, Medicaments Containing the Latter and Use Thereof | OXTR, AVPR2, AVPR1B | GOT1 1882/4885P2RX7 2486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.